Karol Watson

Passionate about #Cardiology, #WIC, and #healthequity. PD @UCLACVfellows

[NEJM Clinician @NEJMClinician]

Spontaneous coronary artery dissection associated with pregnancy appears more clinically severe and potentially less likely to result in a favorable recovery. Karol E. Watson, MD, PhD, FACC (@kewatson), summarizes a recent study: https://t.co/FudA8QsQnn

[UCLA Cardiology Fellowship @uclaCVfellows]

#FlashbackFriday to our fellows covering our @UCLA IM residents on CCU, so they could enjoy their retreat!
#Bruinhearts always showing up for each other and our house staff 💙💛💙
And many thanks to those similarly covering Memorial Day weekend 🫡🫀

[Sanjay Kaul @kaulcsmc]

@NEJMClinician @kewatson @djc795 And Karol’s commentary on CHAMPION-AF is spot on, blunt but incisive!

It is hard to see how anyone can look at the results and declare it is a win for Watchman FLX.

[Sanjay Kaul @kaulcsmc]

@NEJMClinician @djc795 @kewatson Excellent discussion!

Not sure if the distinction between DM with atherosclerosis and without atherosclerosis subset in VESALIUS-CV is as sharp as the investigators’ claims. Baseline CV or all-cause deaths and treatment benefit is indistinguishable among the 2 groups.

[Association of Black Cardiologists @ABCardio1]

Our very own @kewatson co-authored @CircAHA editorial calling 2026 dyslipidemia guidelines "a more precise individualized & equitable" framework for ASCVD prevention. ABC members co-wrote the guidelines. Now they're leading the conversation. https://t.co/Q016pacrcZ

[Eric H Yang, MD @datsunian]

#ACC26 finishes & as always proud of our @UCLAHealth presence, led by our housestaff & alumni!

🔥work with 25+ abstracts/talks/more �� to the mentors who inspire them

And congrats to @ACCinTouch 🌟#KatieBerlacher whose MedEd impact reaches farther than u will ever know ❤️

[JK Han MD @netta_doc]

@kewatson @docHJ @utmbcardiology https://t.co/5CXTsdBdHf

[Karol Watson @kewatson]

@docHJ @utmbcardiology Absolutely NOT safer stroke prevention.

[Karol Watson @kewatson]

@dranulala @IcahnMountSinai @MountSinaiHeart @robmentz @DrMarthaGulati @ShashankSinhaMD @JasonKatzMD @BiykemB @AnkurKalraMD @purviparwani @AndrewJSauer @RyanTedfordMD @noshreza So well deserved 👏🏽👏🏽👏🏽

[UCLA Cardiology Fellowship @uclaCVfellows]

It’s a #MATCH 💙🎊💛!

Welcome to the newest members of our #Bruinhearts Family!

We are so thrilled to have you all join us, and congratulations on your incredible achievements! The future of cardiology is bright and forever beats blue and gold ⭐️💫.

[Eric H Yang, MD @datsunian]

A BIG enthusiastic welcome to our new #bruinhearts @uclaCVfellows class!!

We are so excited to have you join the family and be the field's next superstars!!

@kewatson @netta_doc @HayaseJustin @arafiqmd1 @DOM_UCLA @IntMedAbel

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

@rblument1 presenting at #AHA25 on the intensity & timing of LDL lowering
🫀elevated LDL exposure time matters
🫀risk scores don’t go young enough- waiting to 40 to treat may be too late
🫀don’t wait: cross the line early
@CiccaroneCenter @MichaelJBlaha @SethShayMartin @drstaceyrosen

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

CORE TIMi 72a/b presented as #LBCT #AHA25 studying olezarsen in severe hypertriglyceridemia with primary endpoint percent change in TG
♥️ Global study 1063 patients
♥️placebo compared with two doses
♥️1/4 female 👎🏽

🎯62% placebo control ⤵️ in TG
🎯 significant ⤵️ in non HDL: many achieved TG <150 & 85% <500! 👏🏽
🎯⤵️ in pancreatitis with tx NNT=4
🎯 safe esp at 50 mg dose

📎 https://t.co/W0oXXAnWeM

@ionispharma @NEJM

[WilliamZoghbi @WilliamZoghbi]

@DrMarthaGulati @iamritu @purviparwani @AHAScience @kewatson @JoChikweMD @dramitkhera 2 studies with impressive results of major reduction in Triglycerides and its effects in pts with high TG

[Eric H Yang, MD @datsunian]

Congrats &amp; so thrilled for @UCLAHealthJCCC @UCLAHealth @DOM_UCLA #bruinhearts @ucla_wic @A_SteinMerlob winning the #YIA at #GCOS2025!

🙏 to @alan_garfinkel, @uclaCVfellows @kewatson @IntMedAbel #STAR leadership for your amazing mentorship for this #cardioonc🌟!

@ICOSociety

[NEJM Clinician @NEJMClinician]

Look Carefully for Causes of Myocardial Infarction in Younger Patients: https://t.co/DitsnK5PXp

@kewatson #CardioTwitter

[Kalyanam Shivkumar MD PhD @shivkumarmd]

Remarkable contributions to the field expanding a life saving therapy-great to see the two legends on the stage for 20th Annual VT Symposium- Mark Josephson Memorial Lecture. Our beloved Mark would indeed be smiling! @DrRoderickTung @VTSymposium

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

So lovely to spend time with some of our favorite people! Lovely to be able to have a hike & breakfast with @rblument1 & @WendyPost9 today before their wedding they are attending tonight & before @SmidtHeart GR on Tuesday! We loved being able to see you both! #CVPrev & #friendship are some of the best things in life!

[Gregg Fonarow MD @gcfmd]

Amgen announced the Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that evolocumab significantly reduced the risk of MACE in individuals without a prior history of heart attack or stroke

12,000 high-risk patients, median of 4.5 years

@kewatson

[NEJM Clinician @NEJMClinician]

Data from the COMBINE-AF substudy suggest it may be safe and beneficial to switch frail older patients with atrial fibrillation from warfarin to a direct-acting oral anticoagulant. https://t.co/5zkcv5gIda

#CardioTwitter @kewatson